J Korean Assoc Maxillofac Plast Reconstr Surg.  2010 Mar;32(2):183-188.

A CASE REPORT OF MAXILLARY LEIOMYOSARCOMA WITH REGIONAL LYMPH NODE METASTASIS

Affiliations
  • 1Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyunghee University, Seoul, Korea. leebs@khu.ac.kr

Abstract

Leiomyosarcoma is a malignant neoplasm of smooth muscle origin and mostly originate from the wall of uterus and gastrointestinal tract, but primary leiomyosarcoma of the oral cavity is extremely rare. This tumor has a very poor prognosis due to high recurrence and metastasis rate, with 5 year survival rate of 32%. And regional lymph node metastasis is uncommon event. Complete wide surgical excision is the treatment of choice. A 64-year old man who had a painful ulcerative lesion on the labial & palatal gingiva of #11, 21 visited our department, and was diagnosed as leiomyosarcoma through a biopsy. Partial maxillectomy was carried out, with no following radiotherapy or chemotherapy. After months follow-up, there has been no evidence of recurrence or metastasis. But after months, we clinically find out two enlarged immobile palpable lymph node in right submandibular area of patient. So a biopsy was performed via an extraoral incision under local anesthesia. Histopathologic diagnosis diagnosis of the biopsy was lymph node metastasis of prior existed leiomyosarcoma. We report a case of a primary leiomyosarcoma occurred in a 64 year-old male patient involving the anterior maxillary region with regional lymph node metastasis with a review of literature.

Keyword

Oral leiomyosarcoma; Immunohistochemistry; Lymph node; Metastasis

MeSH Terms

Anesthesia, Local
Biopsy
Follow-Up Studies
Gastrointestinal Tract
Gingiva
Humans
Immunohistochemistry
Leiomyosarcoma
Lymph Nodes
Male
Mouth
Muscle, Smooth
Neoplasm Metastasis
Prognosis
Recurrence
Survival Rate
Ulcer
Uterus
Full Text Links
  • JKAMPRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr